MicroTech Medical (Hangzhou) Co., Ltd. Class H

As of December 31, 2025, MicroTech Medical (Hangzhou) Co., Ltd. Class H carries a market capitalization of 3.27B, placing it among publicly traded companies globally. Its enterprise value stands at 1.66B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

MicroTech Medical (Hangzhou) Co., Ltd. Class H's next confirmed earnings release is scheduled for March 31, 2027.

As of December 31, 2025, MicroTech Medical (Hangzhou) Co., Ltd. Class H has 412.59M shares outstanding.

These figures are as of December 31, 2025.

As of December 31, 2025, MicroTech Medical (Hangzhou) Co., Ltd. Class H maintains a current ratio of 6.39, meaning it holds 6.4x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended December 31, 2025.

As of the close on October 22, 2026, MicroTech Medical (Hangzhou) Co., Ltd. Class H's stock has declined approximately 4.50% over the past 52 weeks. The 50-day moving average sits at 6.95, while the 200-day moving average is 7.33.

As of December 31, 2025, MicroTech Medical (Hangzhou) Co., Ltd. Class H holds 1.72B in cash and equivalents against 101.64M in total debt, resulting in a net debt position of -1.58B. Total book value stands at 2.24B, with working capital of 1.70B providing operational flexibility.